Search clinical trials for: EGFR Mutation

Total 4265 results

Mayo Clinic
GlaxoSmithKline

Completed

Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies

Advanced Solid Malignancies

United States
Pfizer

Completed

Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Assistance Publique - Hôpitaux de Paris

Completed

Study of Factors of Genetic Susceptibility Associated to Severe Caries Phenotype (Cariogene)

Dental Caries

France
China Medical University Hospital

Unknown

Inherited Myokymia: A Clinical and Genetic Study of a Family

A Study of Clinical and Genetic Mutations in a Family of Neuromyotonia, so Called Isaac's Syndrome

Taiwan
Austin Health
Royal North Shore Hospital; Ballarat Health Services; Queen Elizabeth Hospital...

Unknown

Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib (Dux)

Metastatic Colorectal Cancer

Australia
Rambam Health Care Campus

Unknown

Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i

Impotence

Israel
Memorial Sloan Kettering Cancer Center
New York University; Hadassah Medical Organization; New York Presbyterian Hospital and other collaborators

Completed

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk

Breast Cancer | Ovarian Cancer

United States
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

France
AstraZeneca

Completed

Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer (IRESSA&H&N)

Head and Neck Cancer

Switzerland
Odense University Hospital

Completed

Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5

Osteopetrosis

Denmark
Johann Wolfgang Goethe University Hospital

Completed

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Adult Acute Lymphocytic Leukemia

Germany
Actavis Inc.

Completed

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions

Healthy

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer

Lung Cancer
Barts & The London NHS Trust

Unknown

Development of a Biomarker Panel for the Earlier Prediction of Acute Kidney Injury in Patients With Diabetes (BIOMARKERS)

Diabetes Mellitus | Renal Impairment

United Kingdom
Assistance Publique - Hôpitaux de Paris
Novartis; Association Rhumatisme et Travail

Completed

Genetic Study of Families Affected by Paget's Disease of Bone (PAGET)

Paget's Disease of Bone

France
GlaxoSmithKline

Completed

Meta-analysis of Efficacy of Topotecan

Cervical Intraepithelial Neoplasia
Zhejiang Cancer Hospital

Unknown

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Non-small Cell Lung Cancer

China
SCRI Development Innovations, LLC
GlaxoSmithKline; AstraZeneca; Aventis Pharmaceuticals

Completed

Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer

Lung Cancer

United States
Marywood University

Completed

Does Sildenafil Increase Exercise Performance in Air Pollution?

Pulmonary Hypertension | Air Pollution | Exercise Performance | Pulmonary Artery Pressure

United States
University Hospital, Tours

Completed

ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls

Intrahepatic Cholestasis of Pregnancy

France
Hadassah Medical Organization

Unknown

Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer

Breast Cancer | Ovarian Cancer

Israel
Zhejiang Cancer Hospital

Unknown

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0901)

Non-small Cell Lung Cancer

China
AstraZeneca
Laboratorio Progenetica

Completed

Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Brazil
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital; Abbott

Completed

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone

Prostate Cancer | Adenocarcinoma of the Prostate

United States
Eli Lilly and Company
Bristol-Myers Squibb

Completed

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Colorectal Cancer

United States
Eli Lilly and Company
Bristol-Myers Squibb

Completed

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

Colorectal Cancer

United States, Australia, Austria, Belgium, Czech Republic, Finland, France, Germany, Hong Kong, Italy, Netherlands, Norway, Portugal, Slovakia, Sweden, Switzerland, United Kingdom
Eli Lilly and Company
Bristol-Myers Squibb

Completed

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

United States
National Cheng-Kung University Hospital

Unknown

Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients (CKD)

Proteinuria

Taiwan
University of Arizona
National Cancer Institute (NCI)

Completed

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Ovarian Cancer | brca1 Mutation Carrier | brca2 Mutation Carrier

United States
National Taiwan University Hospital

Withdrawn

Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension

Primary and Secondary Pulmonary Hypertension

Taiwan
Bristol-Myers Squibb

Completed

MAD Refractory: Solid Tumor QD w/o Break

HER2 or EGFR Expressing Advanced Solid Malignancies

Spain, France
Samsung Medical Center

Unknown

Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia

Myeloid Leukemia

Korea, Republic of
University of New Mexico

Completed

Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer

Cervical Cancer

United States
New York Presbyterian Hospital
Women At Risk

Unknown

Women At Risk: The High Risk Breast Cancer Program (WAR)

Breast Cancer

United States
Ministry of Health, Labour and Welfare, Japan

Unknown

Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)

Kidney, Polycystic, Autosomal Dominant

Japan
Women's College Hospital
BioResponse

Unknown

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Breast Cancer

Canada
Novartis Pharmaceuticals

Completed

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

Prostate Cancer

United States
National Taiwan University Hospital

Completed

Correlation of Genetic Polymorphism and Livedo Vasculitis

Livedo Vasculitis | Livedoid Vasculitis | Livedoid Vasculopathy | Genetic Pleomorphism | Leiden Mutation

Taiwan
Amgen

Completed

Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer

Metastatic Colorectal Cancer
Yonsei University

Unknown

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Lung Cancer

Korea, Republic of
Massachusetts General Hospital

Completed

Study of Sildenafil in Advanced Heart Failure.

Congestive Heart Failure
Amgen

Completed

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

Solid Tumors | Oncology | Tumors
Memorial Sloan Kettering Cancer Center
American Cancer Society, Inc.

Completed

Adherence to Intensive Surveillance for Hereditary Breast Cancer

Breast Cancer

United States
Oxford University Hospitals NHS Trust

Unknown

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Myelodysplastic Syndromes | Leukemia

United Kingdom
National Institute of Arthritis and Musculoskeletal...

Unknown

The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease

Mitochondrial Myopathy

United States
National Taiwan University Hospital

Unknown

PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

Taiwan
AstraZeneca

Completed

IRESSA™ (Gefitinib) in Breast Cancer Patients

Breast Cancer
Lawson Health Research Institute
The Physicians' Services Incorporated Foundation

Completed

Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease

Chronic Kidney Disease

Canada
Erasmus Medical Center
Leiden University Medical Center; ZonMw: The Netherlands Organisation for Health... and other collaborators

Unknown

Cost-Effectiveness in Bladder Cancer

Bladder Cancer
University of Utah
University of Witwatersrand, South Africa

Completed

A Novel Mutation of the Spectrin Gene

Hereditary Elliptocytosis (HE) | Hereditary Pyropoikilocytosis (HPP)

United States

Search clinical trials for: EGFR Mutation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations